603990.SHG Suzhou Medsys Tech Co Ltd
- Market cap
- CNY 6.93B
- P/E
- 567.3x
- P/B
- 7.07x
- ROE
- 1.0%
- Dividend yield
- 0.15%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603990.SHG undervalued?
Graham numberThe Graham number of Suzhou Medsys Tech Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Suzhou Medsys Tech Co Ltd fundamental analysis
No fundamental analysis for Suzhou Medsys Tech Co Ltd yet.
Suzhou Medsys Tech Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Suzhou Medsys Tech Co Ltd
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive auxiliary diagnosis clinical information system that mines and scientifically a…
Full company profileSuzhou Medsys Tech Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Suzhou Medsys Tech Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 241M | 269M | 284M | 333M | 308M | 354M | 306M | 618M | 464M | 300M | 240M |
| Gross Profit | 166M | 198M | 212M | 240M | 223M | 247M | 215M | 113M | 51.2M | 159M | 138M |
| Operating Income | 24.1M | 52.9M | 60.5M | 53.9M | 48.7M | 51.4M | 44.1M | -262M | -253M | 16.8M | 2.65M |
| EBITDA | 57.1M | 68.0M | 76.2M | 73.3M | 70.1M | 71.8M | 61.8M | -187M | -125M | 48.9M | 19.2M |
| Net Income | 45.2M | 51.1M | 55.5M | 46.9M | 35.4M | 42.0M | 33.6M | -269M | -279M | 39.2M | 8.43M |
| EPS | 0.24 | 0.27 | 0.29 | 0.25 | 0.18 | 0.20 | 0.16 | -0.88 | -0.92 | 0.13 | 0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 690M | 627M | 717M | 760M | 1.52B | 1.31B | 1.63B | 3.92B | 3.16B | 1.25B | 1.17B |
| Total Liabilities | 295M | 193M | 244M | 253M | 280M | 216M | 271M | 2.82B | 2.36B | 403M | 319M |
| Shareholders' Equity | 395M | 434M | 472M | 499M | 1.23B | 1.09B | 1.36B | 1.10B | 800M | 835M | 841M |
| Cash & Short-term Investments | 288M | 80.3M | 169M | 150M | 907M | 641M | 971M | 638M | 159M | 294M | 328M |
| Total Debt | 147M | 70.0M | 104M | 130M | 135M | 80.6M | 163M | 1.33B | 363M | 276M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 32.6M | -6.16M | 48.7M | 22.0M | 100M | 36.0M | 50.5M | -317M | -11.4M | 65.4M | - |
| Capital Expenditure | 28.0M | 40.1M | 16.6M | 12.9M | 8.88M | 41.0M | 24.6M | 600M | 252M | 68.6M | 30.5M |
| Free Cash Flow | 4.55M | -46.3M | 32.0M | 9.15M | 91.6M | -4.95M | 25.9M | -916M | -264M | -3.17M | -25.0M |
| Ratios | |||||||||||
| ROE | 11.4% | 11.8% | 11.7% | 9.4% | 2.9% | 3.8% | 2.5% | -24.6% | -35.0% | 4.7% | 1.0% |
| ROA | 6.5% | 8.2% | 7.7% | 6.2% | 2.3% | 3.2% | 2.1% | -6.9% | -8.8% | 3.1% | 0.7% |
| Net Profit Margin | 18.8% | 19.0% | 19.5% | 14.1% | 11.5% | 11.9% | 11.0% | -43.6% | -60.2% | 13.1% | 3.5% |
| Debt to Equity | 0.37x | 0.16x | 0.22x | 0.26x | 0.11x | 0.07x | 0.12x | 1.21x | 0.45x | 0.33x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Suzhou Medsys Tech Co Ltd dividends
- Dividend yield
- 0.15%
- Forward dividend
- -
- Payout ratio
- 26.1%
- Ex-dividend date
- Jul 1, 2021
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 10.2M | 0.03 | 26.1% |
| 2024 | CNY 26.3M | 0.09 | - |
| 2023 | CNY 17.6M | 0.06 | - |
| 2022 | CNY 3.58M | 0.02 | 10.7% |
| 2021 | CNY 10.8M | 0.05 | 25.7% |
| 2020 | CNY 14.2M | 0.07 | 40.1% |
| 2019 | CNY 16.7M | 0.09 | 35.6% |
| 2018 | CNY 18.7M | 0.10 | 33.7% |
| 2017 | CNY 17.4M | 0.09 | 34.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on Jul 7, 2023.
Who owns Suzhou Medsys Tech Co Ltd
- Insiders 26.27%
- Institutions 2.10%
- Public & others 71.63%
- Shares outstanding 305M
- Free float 233M
Suzhou Medsys Tech Co Ltd company profile
- Company name
- Suzhou Medsys Tech Co Ltd
- Ticker
- 603990.SHG
- ISIN
- CNE100002ZY8
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 632
- Fiscal year end
- December
- Address
- No. 222 Guijia Lane, Suzhou, China, 215021
- Phone
- 86 512 6262 8936
- Website
- medicalsystem.com.cn
About Suzhou Medsys Tech Co Ltd
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive auxiliary diagnosis clinical information system that mines and scientifically analyzes for ICU patients' treatment data with medical information, such as patients' treatment information, inspection information, nursing information, and doctor's advice data. In addition, it offers DoCare operative medical behavior management system that establishes the intelligent management system for the operation resources and personnel behavior; and DoCare emergency clinical information system for management of emergency clinical, including pre-hospital first aid, pre-examination and triage, emergency rescue, emergency under observation, emergency operating room, emergency ICU, and patient outcome. Further, the company provides DoCare pre-hospital first aid clinical information system that provides a unified service platform, which has digital information for emergency command center, emergency doctors, emergency nurses, visiting medical personnel, and patients. Additionally, it offers smart OT, ICU, and emergency solutions; and smart specialty solutions, such as laminar airflow room, clinical pathway, and mobile nursing information systems, as well as central sterile supply department management systems. The company was founded in 2005 and is based in Suzhou, China.
Suzhou Medsys Tech Co Ltd management
5- Mr. Weng KangVice Chairman & GM · born 1968
- Mr. Hao MeiFinancial Director · born 1992
- Mr. Meng Hao LiDeputy GM & Secretary of the Board of Directors · born 1993
- Mr. Di WuDeputy General Manager · born 1968
- Fengying LiuAccounting Supervisor